This week's Fierce LifeSci is brought to you by Bioclinica.
Tuesday, November 2, 2021 | 1pm ET / 10am PT
In a recent survey, 89% of clinical adjudication users agreed clinical adjudication provides value to clinical trials. Why? Because using unbiased experts to evaluate a drug or device against predetermined criteria helps determine patient safety and clinical efficacy. Join two Bioclinica experts for a discussion of these and other survey results to understand how they could impact your studies.
In the webinar, we will discuss:
- The survey findings on the role of clinical adjudication in clinical trials
- The top three hurdles in using clinical adjudication for clinical trials
- The two most valuable services a clinical adjudication partner can provide
- Several considerations to evaluate when selecting a clinical adjudication partner for your next trial
|
| You are currently subscribed as newsletter@newslettercollector.com |
